Protagenic Therapeutics, Inc.
PTIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33,614 | $60,222 | $96,723 | $285,809 |
| - Cash | $1,838 | $1,288 | $215 | $541 |
| + Debt | $0 | $0 | $344 | $318 |
| Enterprise Value | $31,776 | $58,934 | $96,852 | $285,586 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$50 | -$28 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,475 | -$4,499 | -$3,418 | -$4,140 |
| % Margin | – | – | – | – |
| Net Income | -$5,525 | -$5,000 | -$3,556 | -$4,523 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.13 | -1.15 | -0.82 | -1.24 |
| % Growth | 1.7% | -40.2% | 33.9% | – |
| Operating Cash Flow | -$4,217 | -$3,704 | -$1,994 | -$2,799 |
| Capital Expenditures | $0 | -$150 | -$2 | $0 |
| Free Cash Flow | -$4,217 | -$3,854 | -$1,996 | -$2,799 |